T cells are ready for the fight against monkeypox

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• The vaccinia virus (VACV) vaccine was used for smallpox eradication, and its cross-reactivity with monkeypox virus (MPXV) is being investigated.
• Understanding T-cell responses to VACV epitopes is crucial for assessing cross-protection against MPXV.

Purpose of the Study:

• To determine the extent of epitope conservation between VACV and MPXV.
• To evaluate the capacity of VACV-induced epitopes to elicit memory T-cell responses against MPXV.
• To identify potential T-cell epitopes for future orthopoxvirus vaccine strategies.

Main Methods:

• Bioinformatic analysis of VACV and MPXV genomes to identify conserved epitopes.
• In silico prediction of T-cell epitopes.
• Review of existing literature on T-cell responses to VACV.

Main Results:

• A majority of T-cell epitopes induced by VACV vaccines are conserved in MPXV.
• These conserved epitopes can elicit memory T-cell responses.
• An extensive list of potential T-cell epitopes relevant to both viruses was generated.

Conclusions:

• VACV-induced T-cell immunity likely provides cross-protection against MPXV.
• The identified epitopes represent promising targets for novel orthopoxvirus vaccines.
• Further research should validate these findings experimentally.